These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 27742004)

  • 21. Hepatitis B Virus Vaccination in HIV: Immunogenicity and Persistence of Seroprotection up to 7 Years Following a Primary Immunization Course.
    Nicolini LA; Magne F; Signori A; Di Biagio A; Sticchi L; Paganino C; Durando P; Viscoli C
    AIDS Res Hum Retroviruses; 2018 Nov; 34(11):922-928. PubMed ID: 29926738
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Incidence of HAV and HBV infections and vaccination rates in patients with autoimmune liver diseases.
    Wörns MA; Teufel A; Kanzler S; Shrestha A; Victor A; Otto G; Lohse AW; Galle PR; Höhler T
    Am J Gastroenterol; 2008 Jan; 103(1):138-46. PubMed ID: 17970833
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel dendritic-cell-targeting DNA vaccine for hepatitis B induces T cell and humoral immune responses and potentiates the antivirus activity in HBV transgenic mice.
    Yu D; Liu H; Shi S; Dong L; Wang H; Wu N; Gao H; Cheng Z; Zheng Q; Cai J; Zou L; Zou Z
    Immunol Lett; 2015 Dec; 168(2):293-9. PubMed ID: 26475398
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An Immortalized Hepatocyte-like Cell Line (imHC) Accommodated Complete Viral Lifecycle, Viral Persistence Form, cccDNA and Eventual Spreading of a Clinically-Isolated HBV.
    Sa-Ngiamsuntorn K; Thongsri P; Pewkliang Y; Wongkajornsilp A; Kongsomboonchoke P; Suthivanich P; Borwornpinyo S; Hongeng S
    Viruses; 2019 Oct; 11(10):. PubMed ID: 31623162
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Correlation of age with the status of hepatitis B virus replication and histological changes in chronic type B hepatitis.
    Chu CH; Liaw YF; Sheen IS; Chen TJ
    Liver; 1985 Jun; 5(3):117-22. PubMed ID: 4046750
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The ability of Hepatitis B surface antigen DNA vaccine to elicit cell-mediated immune responses, but not antibody responses, was affected by the deglysosylation of S antigen.
    Xing Y; Huang Z; Lin Y; Li J; Chou TH; Lu S; Wang S
    Vaccine; 2008 Sep; 26(40):5145-52. PubMed ID: 18462847
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Functions of Hepatitis B Virus Encoding Proteins: Viral Persistence and Liver Pathogenesis.
    Zhao F; Xie X; Tan X; Yu H; Tian M; Lv H; Qin C; Qi J; Zhu Q
    Front Immunol; 2021; 12():691766. PubMed ID: 34456908
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum HBV DNA plus RNA shows superiority in reflecting the activity of intrahepatic cccDNA in treatment-naïve HBV-infected individuals.
    Huang H; Wang J; Li W; Chen R; Chen X; Zhang F; Xu D; Lu F
    J Clin Virol; 2018; 99-100():71-78. PubMed ID: 29353073
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pathogenesis, diagnosis, prophylaxis, and management of hepatitis B virus infection.
    Cooper B
    Compr Ther; 1989 Jul; 15(7):9-15. PubMed ID: 2527714
    [No Abstract]   [Full Text] [Related]  

  • 30. Antibodies to a synthetic peptide from the preS 120-145 region of the hepatitis B virus envelope are virus neutralizing.
    Neurath AR; Kent SB; Parker K; Prince AM; Strick N; Brotman B; Sproul P
    Vaccine; 1986 Mar; 4(1):35-7. PubMed ID: 2421497
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low hepatitis B virus-specific T-cell response in males correlates with high regulatory T-cell numbers in murine models.
    Kosinska AD; Pishraft-Sabet L; Wu W; Fang Z; Lenart M; Chen J; Dietze KK; Wang C; Kemper T; Lin Y; Yeh SH; Liu J; Dittmer U; Yuan Z; Roggendorf M; Lu M
    Hepatology; 2017 Jul; 66(1):69-83. PubMed ID: 28295453
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An apparent low level of hepatitis B surface antigen (HBsAg) in the presence of significant viral replication.
    Jeffery-Smith A; Hubb J; Oliver A; Tong CY
    J Clin Virol; 2016 Apr; 77():111-4. PubMed ID: 26705961
    [No Abstract]   [Full Text] [Related]  

  • 33. Persistent and transient hepatitis B virus (HBV) infections in children born to HBV-infected mothers despite active and passive vaccination.
    Boot HJ; Hahné S; Cremer J; Wong A; Boland G; van Loon AM
    J Viral Hepat; 2010 Dec; 17(12):872-8. PubMed ID: 20051008
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Natural history of hepatitis B infection].
    Pol S
    Presse Med; 2006 Feb; 35(2 Pt 2):308-16. PubMed ID: 16493335
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Knockdown of Virus Antigen Expression Increases Therapeutic Vaccine Efficacy in High-Titer Hepatitis B Virus Carrier Mice.
    Michler T; Kosinska AD; Festag J; Bunse T; Su J; Ringelhan M; Imhof H; Grimm D; Steiger K; Mogler C; Heikenwalder M; Michel ML; Guzman CA; Milstein S; Sepp-Lorenzino L; Knolle P; Protzer U
    Gastroenterology; 2020 May; 158(6):1762-1775.e9. PubMed ID: 32001321
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Unsolved problems and future perspectives of hepatitis B virus vaccination.
    Tajiri K; Shimizu Y
    World J Gastroenterol; 2015 Jun; 21(23):7074-83. PubMed ID: 26109794
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IL-12-based vaccination therapy reverses liver-induced systemic tolerance in a mouse model of hepatitis B virus carrier.
    Zeng Z; Kong X; Li F; Wei H; Sun R; Tian Z
    J Immunol; 2013 Oct; 191(8):4184-93. PubMed ID: 24048897
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel Hepatitis B Virus Capsid Assembly Modulator Induces Potent Antiviral Responses
    Amblard F; Boucle S; Bassit L; Cox B; Sari O; Tao S; Chen Z; Ozturk T; Verma K; Russell O; Rat V; de Rocquigny H; Fiquet O; Boussand M; Di Santo J; Strick-Marchand H; Schinazi RF
    Antimicrob Agents Chemother; 2020 Jan; 64(2):. PubMed ID: 31712213
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High prevalence of hepatitis B-antibody loss and a case report of
    Sintusek P; Posuwan N; Wanawongsawad P; Jitraruch S; Poovorawan Y; Chongsrisawat V
    World J Gastroenterol; 2018 Feb; 24(6):752-762. PubMed ID: 29456414
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HIV viraemia during hepatitis B vaccination shortens the duration of protective antibody levels.
    O'Bryan TA; Rini EA; Okulicz J; Messner O; Ganesan A; Lalani T; Bavaro MF; O'Connell RJ; Agan BK; Landrum ML
    HIV Med; 2015 Mar; 16(3):161-7. PubMed ID: 25586899
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.